Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib with Gemcitabine/Cisplatin in Stage IV NSCLC
NCT01086254Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of iniparib in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started May 2010; status: completed.
02
Drugs
iniparib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01086254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086254.